Recidiva de hanseníase após 24 doses de poliquimioterapia multibacilar / Relapse in leprosy after 24 months o who multidrug therapy
Hansen. int
;
34(1): 49-53, 2009. ilus
Article
in English
| LILACS, SES-SP, SESSP-ILSLPROD, SES-SP, SESSP-ILSLACERVO, SES-SP
| ID: lil-558290
ABSTRACT
The WHO multidrug therapy has changed the leprosy scenario since its implementation, with a low relapse rate. However, it is still a challenge the duration of treatment for effective cure in patients with high bacillary load. We report in this article a relapse in a patient 9 years after he had finished the therapy. It is also discussed the diagnostic criteria for leprosy relapse and the possibility that some patients require a longer treatment than the usually preconized.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Drug Therapy, Combination
/
Leprosy
Type of study:
Diagnostic study
/
Etiology study
/
Risk factors
Limits:
Animals
/
Humans
/
Male
Language:
English
Journal:
Hansen. int
Year:
2009
Type:
Article
Institution/Affiliation country:
Secretaria de Estado da Saúde/BR
Similar
MEDLINE
...
LILACS
LIS